ABT241227C70000
- 0.00
- 0.000.00%
Abbott Laboratories Newsroom
Wells Fargo Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $133
DexCom, Abbott Agree to Settlement in Patent Litigation
Express News | Abbott: Agreement Will Result in Dismissal of All Pending Cases in Courts, Patent Offices Worldwide - Website
Express News | Abbott: There Are No Financial Payments Associated With Settlement From Either Abbott or Dexcom
Express News | Abbott: Agrees to Global Continuous Glucose Monitoring Litigation Settlement With Dexcom
Abbott Laboratories' (NYSE:ABT) Investors Will Be Pleased With Their Respectable 43% Return Over the Last Five Years
TD Cowen Maintains Abbott Laboratories(ABT.US) With Buy Rating, Raises Target Price to $135
Friday Opens With Falling Prices, but Market Turns Around | Live Stock
Express News | Abbott : TD Cowen Raises Target Price to $135 From $130
Unusual Options Activity: SLB, Z and Others Attract Market Bets, SLB V/OI Ratio Reaches 375.0
RBC Capital Maintains Abbott Laboratories(ABT.US) With Buy Rating, Raises Target Price to $135
Piper Sandler Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $133
Tesla, Bitcoin, S&P 500, Dow, Tank: Thanks a Lot FOMC | Wall Street Today
Abbott Laboratories (ABT) Gets a Buy From Piper Sandler
Express News | FOMC Cuts Interest Rates by 25 Basis Points, Sees Fewer Reductions Next Year
This Is Why You Should Turn Defensive, Underweight Cyclicals – UBS
Dow Breaks Downward Spiral, with FOMC Rate Cut on Deck | Live Stock
Least Shorted S&P 500 Stocks in November
ABT Stock Up on First Successful LBBAP Procedures With AVEIR Pacemaker
Pain Management Devices Global Analysis Report 2024-2034 Featuring Abbott Laboratories, Boston Scientific, Medtronic, Nevro, Baxter, OMRON, Stryker, Teleflex, ICU Medical, AtriCure, and Zynex